Sarepta Therapeutics (SRPT) PT Raised to $96 at Nomura/Instinet on 4Q Beat; 'Pipeline Registration Path & DMD Gene Therapies Emerge in 2018'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. MRK

Go back to Sarepta Therapeutics (SRPT) PT Raised to $96 at Nomura/Instinet on 4Q Beat; 'Pipeline Registration Path & DMD Gene Therapies Emerge in 2018'
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 16.70 -0.56 (3.24%)
Previous Close $17.26    52 Week High $63.73 
Open $17.26    52 Week Low $8.00 
Day High $17.41    P/E N/A 
Day Low $16.69    EPS $-5.69 
Volume 2,746,790